Press Releases

Myomo, Inc. Reports Second Quarter 2017 Results

By Myomo | August 14, 2017 | 0 Comments

CAMBRIDGE, Mass., August 14, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today reports its financial results for the three and six months ended June 30, 2017. Read more.

Myomo, Inc. to Report Second Quarter 2017 Results on August 14, 2017

By Myomo | August 10, 2017 | 0 Comments

Management to hold a conference call at 4:30 p.m. EDT CAMBRIDGE, Mass., August 10th, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it will release its unaudited financial results for the quarter ended June 30, 2017 on Monday, August 14, 2017, after the…

Myomo, Inc. Obtains CE Mark Approval for MyoPro®

By Myomo | July 31, 2017 | 0 Comments

Myomo, Inc. Obtains CE Mark Approval for MyoPro® Enables Company to Start Providing Devices in Europe CAMBRIDGE, Mass., July 31, 2017 – Myomo, Inc. (NYSE MKT: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it has obtained CE Mark approval for commercial sale of its next-generation MyoPro myoelectric arm orthosis…

Myomo Expands Management Team

By Myomo | July 27, 2017 | 0 Comments

Myomo Expands Management Team to Accelerate Commercialization of MyoPro® Powered Orthosis CAMBRIDGE, Mass., July 25, 2017 – Myomo®, Inc. (NSYE MKT: MYO), a commercial stage medical robotics company, today announced the expansion of its management team with three new full-time positions in medical affairs, sales and marketing. The expansion marks the company’s accelerated commercialization of…

Myomo, Inc. Introduces Center of Excellence Program

By Myomo | July 12, 2017 | 0 Comments

Nationwide Roster of Top O&P Practices Supports MyoPro® Powered Orthosis Nationwide Roster of Top O&P Practices Supports MyoPro® Powered Orthosis Cambridge, MA., July 12, 2017 – Myomo®, Inc. (NSYE MKT: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced the launch of its Center of Excellence (CoE) program, which recognizes top…

Myomo, Inc. Announces Publication of Significant Clinical Research

By Myomo | June 27, 2017 | 0 Comments

Peer-reviewed Results Indicate Significant Reduction in Upper Extremity Impairment with MyoPro®, with Changes Exceeding Clinically Important Thresholds CAMBRIDGE, Mass., June 27, 2017 – Myomo, Inc. (NYSE MKT: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced publication of an investigator-led clinical study in the Archives of Physical Medicine and Rehabilitation. The…

Myomo, Inc. Launches MyoPro® 2

By Myomo | June 13, 2017 | 0 Comments

Powered Arm Orthosis Features Interchangeable, Extended-life Rechargeable Batteries Myomo, Inc. (NSYE MKT: MYO) today announced the launch of its next-generation MyoPro® myoelectric arm orthosis (powered brace), the only lightweight wearable device that can restore function in the paralyzed or weakened arms and hands of individuals who have suffered a stroke, spinal cord or nerve injury,…

myomo-rings-closing-bell

Myomo, Inc. Trades On The New York Stock Exchange MKT

By Myomo | June 12, 2017 | 0 Comments

Myomo, Inc. today announces that following the close of its initial public offering, its common shares will begin trading on the NYSE. Read press release.

MyoPro Motion G

Myomo, Inc. Completes Historic Initial Public Offering

By Myomo | June 10, 2017 | 1 Comment

First company to go public on the NYSE MKT under JOBS Act Regulation A+ Cambridge, MA., June 9, 2017 – Myomo, Inc. (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced the completion of its initial public offering (IPO) under SEC Regulation A+, raising $5.0 Million through the sale of 665,498 shares…

Myomo Launches IPO Via Jobs Act Regulation A+ with Sights Set on NYSE MKT Listing

By Myomo | March 15, 2017 | 1 Comment

Everyday Investors Can Now Buy Stock in Pioneering Wearable Medical Robotics Company Cambridge, Mass. (March 15, 2017) ​– Myomo, Inc., ​a commercial stage medical robotics Company, ​today announced a Regulation A+ initial public offering that allows any investor the opportunity to invest in the Company’s vision for expanded mobility for those suffering from neurological disorders and…